Eli Lilly's Orforglipron shines in Phase III trials, potentially leading diabetes and obesity treatment by 2026. See what to ...

Eli Lilly plans to manufacture its new weight-loss pill in the US for patients around the world as Trump presses companies to ...

But this one, for Lilly’s first diabetes and weight-loss pill based on the GLP-1 hormone, was particularly fraught. Days ...

You can reach Katie on Signal at palmer.01. Amid ongoing battles over alternate supplies of blockbuster weight loss drugs, Eli Lilly filed new lawsuits against four telehealth firms and their ...

Eli Lilly released new data around a daily weight-loss pill ... We're gonna make this medicine here in the United States. We're building the largest, what we call API factory, which is ...

Eli Lilly reported promising results from a study of its experimental oral drug that could rival popular injections to treat ...

Eli Lilly announced the results of a clinical trial for its new pill, which the company said causes nearly 8% weight loss at ...

Eli Lilly CEO David Ricks speaks during a press conference, on the day of a groundbreaking ceremony to mark the beginning of the construction of the new plant, in Alzey, Germany, April 8 ...

Eli Lilly (LLY) CEO Dave Ricks said Friday that ... loss — both of which are administered by injection. “We’re building inventory so that when we introduce [orforglipron] in 2026, we can ...